
    
      The purpose of the study was to carry out a pilot study on the short-term effect of
      intravitreal Bevacizumab (Avastin) injection on retinal blood-flow velocity and test whether
      the short-term haemodynamic changes could predict the longer term clinical result of the
      treatment.
    
  